Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 39 studies | 29% ± 11% | |
fibroblast | 35 studies | 27% ± 9% | |
pericyte | 33 studies | 32% ± 12% | |
smooth muscle cell | 27 studies | 32% ± 11% | |
B cell | 25 studies | 27% ± 7% | |
ciliated cell | 19 studies | 37% ± 16% | |
naive B cell | 17 studies | 26% ± 8% | |
memory B cell | 17 studies | 26% ± 7% | |
endothelial cell of lymphatic vessel | 15 studies | 24% ± 8% | |
capillary endothelial cell | 13 studies | 27% ± 5% | |
myofibroblast cell | 13 studies | 32% ± 14% | |
endothelial cell of vascular tree | 12 studies | 38% ± 11% | |
mast cell | 11 studies | 21% ± 3% | |
endothelial cell of artery | 10 studies | 35% ± 11% | |
glutamatergic neuron | 9 studies | 40% ± 24% | |
vein endothelial cell | 8 studies | 28% ± 8% | |
connective tissue cell | 8 studies | 29% ± 9% | |
epithelial cell | 7 studies | 28% ± 9% | |
astrocyte | 7 studies | 30% ± 8% | |
cardiac muscle cell | 5 studies | 25% ± 5% | |
abnormal cell | 5 studies | 24% ± 4% | |
GABAergic neuron | 4 studies | 43% ± 16% | |
epithelial cell of proximal tubule | 3 studies | 19% ± 2% | |
Mueller cell | 3 studies | 21% ± 5% | |
rod bipolar cell | 3 studies | 20% ± 3% | |
muscle cell | 3 studies | 47% ± 22% | |
mesothelial cell | 3 studies | 33% ± 16% | |
neuron | 3 studies | 34% ± 12% | |
interneuron | 3 studies | 42% ± 20% | |
oligodendrocyte | 3 studies | 24% ± 6% | |
enteroendocrine cell | 3 studies | 26% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 3796.15 | 258 / 258 | 100% | 95.12 | 230 / 230 |
kidney | 100% | 3927.35 | 89 / 89 | 100% | 82.38 | 899 / 901 |
thymus | 100% | 3778.72 | 651 / 653 | 100% | 90.70 | 605 / 605 |
prostate | 100% | 5595.68 | 244 / 245 | 100% | 61.49 | 500 / 502 |
ovary | 100% | 2805.30 | 180 / 180 | 99% | 53.94 | 426 / 430 |
brain | 99% | 3220.32 | 2609 / 2642 | 100% | 102.89 | 705 / 705 |
breast | 100% | 3866.20 | 459 / 459 | 98% | 51.03 | 1093 / 1118 |
intestine | 100% | 6778.52 | 962 / 966 | 97% | 46.88 | 512 / 527 |
lung | 100% | 7942.51 | 577 / 578 | 96% | 42.82 | 1108 / 1155 |
bladder | 100% | 9080.38 | 21 / 21 | 96% | 50.75 | 482 / 504 |
skin | 86% | 1702.50 | 1564 / 1809 | 100% | 88.09 | 471 / 472 |
uterus | 99% | 6177.61 | 169 / 170 | 82% | 53.77 | 375 / 459 |
stomach | 84% | 3534.40 | 300 / 359 | 95% | 45.62 | 273 / 286 |
liver | 77% | 1026.86 | 175 / 226 | 99% | 35.60 | 401 / 406 |
esophagus | 91% | 6594.93 | 1310 / 1445 | 85% | 25.11 | 156 / 183 |
pancreas | 28% | 350.23 | 91 / 328 | 99% | 56.30 | 176 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 86.15 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 151.62 | 29 / 29 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.19 | 1 / 1 |
blood vessel | 100% | 7445.17 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 4461.67 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 100% | 7452.10 | 858 / 861 | 0% | 0 | 0 / 0 |
spleen | 99% | 2185.82 | 238 / 241 | 0% | 0 | 0 / 0 |
muscle | 98% | 3112.46 | 790 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 28.15 | 37 / 45 |
peripheral blood | 11% | 160.15 | 98 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042308 | Biological process | negative regulation of protein import into nucleus |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_2000480 | Biological process | negative regulation of cAMP-dependent protein kinase activity |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004862 | Molecular function | cAMP-dependent protein kinase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PKIG |
Protein name | cAMP-dependent protein kinase inhibitor gamma cAMP-dependent protein kinase inhibitor gamma (PKI-gamma) cAMP-dependent protein kinase inhibitor |
Synonyms | hCG_38104 |
Description | FUNCTION: Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains. . FUNCTION: Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains. . FUNCTION: Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains. . |
Accessions | ENST00000372891.7 ENST00000372886.6 ENST00000372892.7 Q9Y2B9 ENST00000349959.3 ENST00000372889.5 ENST00000372894.7 ENST00000372887.5 Q5H937 Q549H9 |